YSB Inc. (9885.HK)
HKSE · HKD · Healthcare · Pharmaceutical Retailers
HK$3.43 (-1.29%) as of
Key statistics
- Market cap
- 2.35B
- P/E (TTM)
- 11.43
- EPS (TTM)
- 0.300
- Dividend yield
- 3.60%
- 52-week range
- 2.960 – 10.360
- Beta
- 0.44
- Revenue (TTM)
- 21.41B
- Profit margin
- 0.87%
- Volume
- 688.22k
About YSB Inc.
YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. In addition, the company engages in the wholesale and retail of pharmaceutical and healthcare products. Further, it provides medical testing services; logistics services; and ClouDiagnos. YSB Inc. was founded in 2015 and is headquartered in Guangzhou, China.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Guangzhou, China
- Employees
- 6,795
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.